Folks worldwide have been starving for good news about how to deal with the COVID-19 pandemic, and Thursday, a Toronto-based company furnished some of it.
Datametrex AI Limited (TSX-Venture:DM) entered into an agreement this week, securing the rights to import the iONEBIO INC’s iLAMP Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR assay system) into Canada,
It means Datametrex also obtained rights to sell the tests into other countries around the globe, including the United States. Datametrex has developed strong relationships with many large multi-national companies in South Korea. As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.
The COVID-19 test kits are manufactured by a South Korean concern, and are the same test kits that have been successfully used in South Korea in their “drive-through” testing stations. This kit has also been used to test every traveler entering into South Korea and those testing positive for Covid-19 were immediately isolated.
Datametrex believes a key factor that allowed South Korea to slow the spread of COVID-19 was its ability to swiftly identify and quarantine those infected by testing millions of people using these test kits
And did it ever show in the demand for shares in DM, which sprang ahead 7.5 cents, or 136.4%, to 13 cents, on volume of 26.6 million shares.
